{"id":"NCT02105636","sponsor":"Bristol-Myers Squibb","briefTitle":"Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)","officialTitle":"An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-05-29","primaryCompletion":"2015-11-06","completion":"2021-09-10","firstPosted":"2014-04-07","resultsPosted":"2017-01-11","lastUpdate":"2022-10-05"},"enrollment":361,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Squamous Cell Carcinoma of the Head and Neck"],"interventions":[{"type":"DRUG","name":"Nivolumab","otherNames":["BMS-936558"]},{"type":"DRUG","name":"Cetuximab","otherNames":[]},{"type":"DRUG","name":"Methotrexate","otherNames":[]},{"type":"DRUG","name":"Docetaxel","otherNames":[]}],"arms":[{"label":"Arm A: Nivolumab","type":"EXPERIMENTAL"},{"label":"Arm B: Cetuximab/Methotrexate/Docetaxel","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to find out whether Nivolumab will significantly improve overall survival as compared to therapy of investigator's choice in patients with recurrent or metastatic head and neck carcinoma.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"From date of randomization to date of death (Up to approximately 18 months)","effectByArm":[{"arm":"Nivolumab 3mg/kg","deltaMin":7.49,"sd":null},{"arm":"Investigators Choice","deltaMin":5.06,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0101"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":64,"countries":["United States","Argentina","Brazil","Canada","France","Germany","Hong Kong","Italy","Japan","Netherlands","South Korea","Spain","Switzerland","Taiwan","United Kingdom"]},"refs":{"pmids":["32583557","31422216","30972702","30944020","29884413","28939066","28651929","27718784"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","https://www.bmsstudyconnect.com/s/US/English/USenHome","https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm","https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html"]},"adverseEventsSummary":{"seriousAny":{"events":165,"n":236},"commonTop":["Fatigue","Anaemia","Nausea","Diarrhoea","Decreased appetite"]}}